Summary: | A series of new derivatives (<strong>5</strong>–<strong>29</strong>) of marine-derived bostrycin (<strong>1</strong>) were synthesized. The <em>in vitro</em> cytotoxic activities of all compounds were evaluated against MCF-7, MDA-MB-435, A549, HepG2, HCT-116 and MCF-10A cells using the MTT method. The compounds <strong>7</strong>, <strong>8</strong>, <strong>22</strong>, <strong>23</strong>, <strong>25</strong>, <strong>28</strong> and <strong>29</strong><strong> </strong>of the total showed comparable activity to epirubicin, the positive control, against the tested cancer cell lines. However, these compounds also exhibited cytotoxicity towards MCF-10A cells. The structure-activity relationship (SAR) of bostrycin derivatives was also discussed based on the obtained experimental data.
|